Format

Send to

Choose Destination
See comment in PubMed Commons below
J Allergy (Cairo). 2011;2011:752098. doi: 10.1155/2011/752098. Epub 2011 Jan 11.

An atypical cutaneous reaction to rivastigmine transdermal patch.

Author information

1
Department of Dermatology, Universit√° di Roma "La Sapienza", Viale del Policlinico, 155, 00161 Rome, Italy.

Abstract

Rivastigmine is a cholinesterase inhibitor which improves cognitive function and is currently being used in patients with mild to moderate Parkinson's and Alzheimer's dementia. This drug can be given orally or topically, as transdermal patch. The latter form is currently used for most excellent compliance and few side effects. The most common cutaneous side effects are irritative dermatitis. We report the second case of active sensitization by the rivastigmine-patch in a patient suffering from Alzheimer's dementia.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center